Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment

A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis.

Leave a Reply

Your email address will not be published. Required fields are marked *